Sirolimus and steroids for rapid return of coronary blockages
Treatments studied
Part of Heart & circulation, Pain clinical trials.
This trial tests a combination of sirolimus and steroids for people whose coronary stent blockages return quickly. It aims to see if this treatment can prevent further blockages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older
- You understand the study and can sign a consent form
- You have had rapid return of a stent blockage (called RECUR)
- You had a successful heart procedure to open the blockage within the last two weeks
- You are taking standard heart medications and your treatment goals are met
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug-coated heart stent (sirolimus with ascorbic acid, a form of vitamin C) works as well as another type (everolimus) for patients with blocked coronary arteries. Both drugs help prevent the stent from becoming blocked again.
This study tests if a special balloon coated with sirolimus can help stabilize or shrink non-blocking plaques in your heart arteries after a recent heart attack. You may be eligible if you've had a heart attack in the past 3 months and have at least two non-blocking plaques in different arteries.
This study follows adults who have fast, unexplained re-narrowing of a coronary stent, to better understand what causes it and how to monitor it. You may help by allowing the study team to collect medical information over time.
This study tests a coronary stent approach for people with significantly blocked heart arteries. It may help by improving blood flow, and it compares treatment in a structured way while monitoring safety and outcomes.
This trial tests if anti-inflammatory drugs like prednisone or colchicine can prevent stents from blocking again in people who have already had multiple stent blockages. It may offer a new treatment option for those with recurrent in-stent restenosis.
This trial tests whether a special drug-coated balloon (“MagicTouch”) can treat re-narrowing inside a previously placed stent. It may help patients whose stent has become blocked again, by improving blood flow and reducing repeat narrowing.
Hear when a new In-stent Restenosis Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.